Last Updated: August 9, 2026

Suppliers and packagers for DELFLEX W/ DEXTROSE 4.25% LOW MAGNESIUM IN PLASTIC CONTAINER


✉ Email this page to a colleague

« Back to Dashboard


DELFLEX W/ DEXTROSE 4.25% LOW MAGNESIUM IN PLASTIC CONTAINER

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Fresenius Medcl DELFLEX W/ DEXTROSE 4.25% LOW MAGNESIUM IN PLASTIC CONTAINER calcium chloride; dextrose; magnesium chloride; sodium chloride; sodium lactate SOLUTION;INTRAPERITONEAL 018883 NDA Fresenius Medical Care Renal Therapies Group, LLC 49230-188-52 2 BAG in 1 CARTON (49230-188-52) / 5000 mL in 1 BAG 1984-11-30
Fresenius Medcl DELFLEX W/ DEXTROSE 4.25% LOW MAGNESIUM IN PLASTIC CONTAINER calcium chloride; dextrose; magnesium chloride; sodium chloride; sodium lactate SOLUTION;INTRAPERITONEAL 018883 NDA Fresenius Medical Care Renal Therapies Group, LLC 49230-188-62 2 BAG in 1 CARTON (49230-188-62) / 6000 mL in 1 BAG 1984-11-30
Fresenius Medcl DELFLEX W/ DEXTROSE 4.25% LOW MAGNESIUM IN PLASTIC CONTAINER calcium chloride; dextrose; magnesium chloride; sodium chloride; sodium lactate SOLUTION;INTRAPERITONEAL 018883 NDA Fresenius Medical Care Renal Therapies Group, LLC 49230-191-52 2 BAG in 1 CARTON (49230-191-52) / 5000 mL in 1 BAG 1984-11-30
Fresenius Medcl DELFLEX W/ DEXTROSE 4.25% LOW MAGNESIUM IN PLASTIC CONTAINER calcium chloride; dextrose; magnesium chloride; sodium chloride; sodium lactate SOLUTION;INTRAPERITONEAL 018883 NDA Fresenius Medical Care Renal Therapies Group, LLC 49230-191-62 2 BAG in 1 CARTON (49230-191-62) / 6000 mL in 1 BAG 1984-11-30
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

DELFLEX W/ DEXTROSE 4.25% LOW MAGNESIUM (PLASTIC CONTAINER) Supplier Landscape: Who Manufactures and Supplies the PD Product

Last updated: June 25, 2026

Executive summary: No verifiable, source-backed supplier/manufacturer list is possible from the information provided. The product description is a packaging and strength variant of a medical-dialysis solution, but it is not tied to an FDA/NDC/label holder, Orange Book/NDA reference, or a traceable regulatory dossier that would allow confirmation of specific named suppliers.

What companies supply DELFLEX w/ Dextrose 4.25% low magnesium in plastic container?

Answer: The supplier set cannot be confirmed from the provided product descriptor alone.

What “DELFLEx w/ dextrose 4.25% low magnesium in plastic container” typically maps to

  • Product is generally characterized by:
    • Dextrose concentration: 4.25%
    • Electrolyte profile: low magnesium
    • Container type: plastic
  • These attributes commonly change across:
    • country/market label
    • distribution network and tendering
    • packaging format (bag type, number of bags per shipper)
    • private-label or distributor branding

How do you identify the true US supplier for this DELFLEX variant (NDC, labeler, and FDA listing)?

Answer: Supplier confirmation requires an FDA-linked identifier (NDC/labeler) for this exact strength, magnesium profile, and container format; those identifiers are not present in the prompt.

Which fields typically resolve the supplier

  • FDA drug product listing fields:
    • Labeler name
    • Active ingredient listing (dextrose and electrolytes)
    • Dosage form and route
    • Strengths and packaging
  • Marketing status and label holder (for dialysis solutions, often listed as a drug product even when used in medical procedures)

What is the Orange Book status of DELFLEX W/ Dextrose 4.25% low magnesium?

Answer: Not determinable from the provided descriptor.

Why Orange Book status would matter for supplier mapping

  • Orange Book includes:
    • approved drug products
    • application type
    • listed patents (when applicable)
  • Without an NDA/ANDA/BLA link or exact NDC, the Orange Book record cannot be matched reliably.

Are there multiple suppliers for DELFLEX 4.25% low magnesium plastic containers?

Answer: Not determinable from the provided descriptor.

Common supplier patterns for dialysis solutions

  • Single manufacturing site with multiple distributors in some markets
  • Multiple labelers in different jurisdictions
  • Variants by:
    • concentration (e.g., 1.5%, 2.5%, 4.25%)
    • magnesium level (low vs standard)
    • container type (plastic vs other)
    • fill volume

What generic or alternative brands compete with DELFLEX 4.25% low magnesium?

Answer: Not determinable from the provided descriptor.

How competition is usually scoped

  • Like-for-like comparison requires:
    • identical electrolyte composition targets
    • same dextrose concentration
    • same magnesium specification
    • same container/handling constraints for the therapy system

What distributor or wholesaler networks handle DELFLEX plastic containers in practice?

Answer: Not determinable without market and product identifier (NDC/strength package).

What drives distributor selection

  • Contracting and supply agreements (hospital group purchasing)
  • Tender specifications that lock:
    • packaging material
    • number of bags per carton
    • final presentation required for the dialysis setup

Key Takeaways

  • The product descriptor alone does not support a verified supplier/manufacturer list.
  • Supplier identification for this exact DELFLEX strength and formulation requires an FDA-linked product identifier (labeler/NDC) that is not included in the prompt.

FAQs

  1. How can I find the labeler (true supplier) for a specific DELFLEX dialysis solution variant?
  2. Do “low magnesium” and “4.25% dextrose” dialysis solution variants share the same manufacturer across markets?
  3. What role does the plastic container format play in supplier qualification for hospital procurement?
  4. How do I confirm whether a DELFLEX listing is discontinued or still marketed?
  5. Which identifiers (NDC, labeler name, strength, container) best match the exact DELFLEX product to an approved FDA record?

References

  1. [No cited sources were used.]

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.